1255 — TATA Health International Holdings Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -130.02% | ||
Return on Equity | -67.65% | ||
Operating Margin | -13.18% |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 358.01 | 341.77 | 155.36 | 160.93 | 144.61 | n/a | n/a | -21.46% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
TATA Health International Holdings Ltd, formerly S. Culture International Holdings Ltd, is an investment holding company principally engaged in the sale of footwear products. The Company operates business through four segments. The Footwear Business segment is involved in the sale of footwear products under the brand name of Clarks, Josef Seibel, The Flexx and Petite Jolie. The Financial Services Business segment is involved in the provision of advisory services in securities, investment management services and advisory services in corporate finance. The Healthcare Business segment is involved in the sale of healthcare products under the brand name of AXS and Bio Lands and others, and Aptamil milk powder. The Online Medical Services Business segment provides medical services such as medical advisory and consultation.
Directors
- Jun Yang CHM (37)
- Wenjing Lai CFO (42)
- Mei Yin Chan OTH (59)
- Wai Man Chan OTH (53)
- Yuen Fan Chu OTH (45)
- Tin Yu Wong SEC
- Anhua Chen NED (52)
- Chun Ho Chu NED (45)
- Jun Lin NED (38)
- Zheming Lin NED (39)
- Yuying Tan NID (47)
- Rongxing Xie NID (70)
- Haifeng Yan NID (51)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- December 17th, 2012
- Public Since
- July 11th, 2013
- No. of Employees
- 120
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 242,845,000

- Address
- Flat F-J, 11F,Kwai Tak Industrial Centre, Hong kong
- Web
- http://www.s-culture.com/
- Phone
- +852 null26120003
- Auditors
- HLB Hodgson Impey Cheng
Upcoming Events for 1255
Similar to 1255
3DG Holdings International
Stock Exchange of Hong Kong Limited
AESO Holding
Stock Exchange of Hong Kong Limited
Asia Commercial Holdings
Stock Exchange of Hong Kong Limited
Ausupreme International Holdings
Stock Exchange of Hong Kong Limited
Autostreets Development
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:35 UTC, shares in TATA Health International Holdings are trading at HK$0.30. This share price information is delayed by 15 minutes.
Shares in TATA Health International Holdings last closed at HK$0.30 and the price had moved by -50% over the past 365 days. In terms of relative price strength the TATA Health International Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -49.43% over the past year.
There is no consensus recommendation for this security.
Find out moreTATA Health International Holdings does not currently pay a dividend.
TATA Health International Holdings does not currently pay a dividend.
TATA Health International Holdings does not currently pay a dividend.
To buy shares in TATA Health International Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.30, shares in TATA Health International Holdings had a market capitalisation of .
Here are the trading details for TATA Health International Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1255
Based on an overall assessment of its quality, value and momentum TATA Health International Holdings is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like TATA Health International Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -2.19%.
As of the last closing price of HK$0.30, shares in TATA Health International Holdings were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The TATA Health International Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
TATA Health International Holdings' management team is headed by:
- Jun Yang - CHM
- Wenjing Lai - CFO
- Mei Yin Chan - OTH
- Wai Man Chan - OTH
- Yuen Fan Chu - OTH
- Tin Yu Wong - SEC
- Anhua Chen - NED
- Chun Ho Chu - NED
- Jun Lin - NED
- Zheming Lin - NED
- Yuying Tan - NID
- Rongxing Xie - NID
- Haifeng Yan - NID